Medicare Part D in 2027: The $2,400 Cap, the $700 Deductible, and What Else Changes
The letter came in September. Maybe October. It sat on the kitchen table for three days before you opened it. You knew what it was. The annual notice. The one that tells you your drug plan is doing something different next year. Same envelope, same font, same feeling in your stomach.
For 2027, that feeling has some specific numbers attached to it. The out-of-pocket cap goes up. The deductible goes up. A subsidy program that kept premiums low for a few years ends. And fifteen more drugs get their prices negotiated down.
That's the short version. Here's the longer one.
The $2,400 Cap, What It Means for Your Wallet
If you have Medicare Part D, there is a ceiling on what you pay out of pocket for covered prescription drugs. In 2026, that ceiling was $2,100. In 2027, it moves to $2,400.
You hit that number, you pay nothing else for covered drugs for the rest of the plan year. That's the deal.
Is $300 more a big deal? Depends on your prescriptions. If you take a couple of generics, you'll never get close to the cap. If you're on specialty medications, you'll hit it in February. The cap is a safety net, and the net got a little higher.
The reason for the increase is baked into the law. The cap is indexed to inflation. The Inflation Reduction Act set the structure. The number adjusts. Nobody called you to ask if you wanted it to go up. That's how it works.
The $700 Deductible, A Number That Changed
The standard Part D deductible goes from $615 to $700 in 2027. That's a 13.8 percent jump. Not all plans use the full deductible. Some use a lower one. Some apply it only to certain tiers of drugs. But the standard number is $700.
Here's what that means in practice. You pay the first $700 of your drug costs before your plan starts picking up its share. Unless your plan has a different structure. Read your plan documents. The deductible is not a flat rule. It's a starting point.
Some plans have no deductible. Some have a partial one. The $700 figure is the maximum the government allows for the standard benefit. Your plan might charge less. It might not.
Premiums, The Stabilization Demonstration Ends
For the past few years, the federal government ran something called the Part D Premium Stabilization Demonstration. It was a temporary subsidy program. Insurance companies got federal support to keep premiums from spiking while they adjusted to the new benefit structure.
That program ends after 2026.
What does that mean for you? The national base beneficiary premium, the starting point for calculating plan-specific premiums, goes from $38.99 to $41.33 in 2027. The average stand-alone Part D premium is projected to rise less than $1 per month, from $35.09 to $36.
That's the average. Averages are liars sometimes. The KFF analysis shows that some people will see premium reductions if they keep their current plan. Others will see increases of $50 a month or more if they don't switch.
There will be no zero-premium stand-alone Part D plans for people who don't receive low-income subsidies in 2027. All four million PDP enrollees who paid no monthly premium in 2026 will face higher premiums in 2027, whether they keep their current plan or switch to a new one.
That's the part that bites. The zero-premium plan is gone.
The Medicare Prescription Payment Plan, Spreading the Pain
This one is not new for 2027. It started in 2025. But it's still around, and a lot of people still don't know about it.
The Medicare Prescription Payment Plan, sometimes called the Medicare Smoothing program, lets you spread your out-of-pocket prescription drug costs across the calendar year instead of paying them all at once.
You know how it goes. You pick up a prescription in January. It costs $600. You pay $600. Your bank account feels it. Then you pick up another one in February. Same thing.
The smoothing program changes that. You pay a monthly bill instead. Same total cost. Different distribution.
If you're already enrolled and you stay in the same Part D plan, your participation automatically renews for 2027. You don't have to do anything. If you want to join, you have to opt in. It's not automatic. That's the part people miss.
The program does not lower your drug costs. It just changes when you pay them. That's the whole thing. It's a cash-flow tool. If you have high drug costs early in the year and your budget can't absorb the hit, this helps. If you can handle the lump sums, you don't need it.
Drug Price Negotiation, 15 More Drugs Get Cheaper
Here's where the government does something that actually lowers prices rather than just rearranging them.
Under the Inflation Reduction Act, Medicare can negotiate prices directly with drug manufacturers for certain high-cost medications. The first round of negotiated prices took effect in 2026. The second round takes effect in January 2027.
Fifteen drugs are on that list for 2027. The negotiated prices, called Maximum Fair Prices, are estimated to generate a net savings of 44 percent, or about $12 billion, compared to what Medicare would have paid otherwise.
What drugs? The list includes medications for diabetes, cancer, autoimmune conditions, and cardiovascular disease. Wegovy, the GLP-1 drug, is among them.
If you take one of those drugs, your out-of-pocket costs may drop. Or they may not, depending on your plan's formulary. Negotiated prices set the ceiling for what Medicare pays. Your plan's cost-sharing structure determines what you pay. The two are related. They are not the same thing.
Formularies and Coverage, What Might Change for Your Medications
This is where the surprises live.
Every year, Part D plans change their formularies. The formulary is the list of drugs the plan covers. Drugs move between tiers. Some get added. Some get removed. Some require prior authorization now. Some have quantity limits.
The 2027 changes are no different. The addition of negotiated prices for fifteen drugs may cause some plans to adjust their formulary strategies. Plans may change which drugs they prefer, which ones they cover, and what they charge for them.
Here's the practical reality. Your medication might be on your plan's formulary in 2026. It might not be on the formulary in 2027. Or it might be on a higher tier, which means you pay more. Or it might require your doctor to submit prior authorization paperwork before the plan covers it.
You won't know until you look. The plan sends you the Annual Notice of Change. That document lists what's different. It's not a fun read. But it's the one that matters.
Star Ratings, A Quieter Change That Matters
Star Ratings are the quality scores Medicare assigns to health and drug plans. They range from one to five stars. People use them to compare plans. The scores matter.
For 2027, CMS is making two changes to the Part C and Part D Star Ratings system. First, the agency is dropping the "Excellent Health Outcomes for All" reward for the 2027 Star Ratings. Second, it's removing eleven measures from the system, measures that focused on administrative tasks or areas where most plans already perform well.
The reasoning is straightforward. If most plans score well on a measure, that measure doesn't help people tell plans apart. CMS is trying to make the ratings more useful.
Does this affect your coverage directly? Not really. It affects how plans are evaluated. It might affect how plans behave. It might affect which plans get bonuses. The ripple effects are real. But the immediate impact on your prescriptions is indirect.
What You Should Do Before January 2027
Fall Open Enrollment runs from October 15 through December 7, 2026. Changes you make during that window take effect January 1, 2027.
Here's what to do.
Read your Annual Notice of Change. It's the document your plan sends every fall. It lists the changes for next year, premiums, deductibles, copays, formulary changes. Read it with a pen. Mark the pages that affect your medications.
Check your medications against the 2027 formulary. Your plan's website has the formulary. Your doctor's office might have it too. Look up each drug you take. Find out what tier it's on, what it costs, and whether it requires prior authorization or has quantity limits.
Compare your plan to others in your area. The Medicare Plan Finder on Medicare.gov lets you enter your medications and see what different plans would cost you. It's not a perfect tool. It's better than guessing.
Consider the Medicare Prescription Payment Plan. If your drug costs are high and front-loaded, the smoothing program might help your cash flow. If you're already enrolled, check that you're still enrolled. If you're not, decide whether you want to be.
Check your eligibility for Extra Help. The Low-Income Subsidy program, also called Extra Help, helps people with limited income and resources pay for Part D premiums, deductibles, and copays. If you qualify, the changes for 2027 may affect you differently.
Talk to someone if you need to. The Medicare Rights Center, your State Health Insurance Assistance Program (SHIP), and your plan's customer service line are all places to get answers. You don't have to figure this out alone. You just have to figure it out before December 7.
No Panic, Just Attention
Here's the thing about Medicare Part D changes. They happen every year. The numbers move. The rules adjust. The plans change their formularies. The letters arrive. The deadlines pass.
2027 is not a catastrophe. It's not a windfall either. The out-of-pocket cap goes up by $300. The deductible goes up by $85. The zero-premium plans are gone. Fifteen more drugs get negotiated prices. The payment plan is still there if you want it.
The people who get hurt are the ones who don't look. The ones who open the envelope, skim the first page, and put it in the pile with the cable bill and the insurance statement. The ones who assume nothing changed.
Something changed. It always does.
You have until December 7. That's enough time to read the letter, check the formulary, run the numbers, and make a decision. Or not make one. Either way, it should be a decision.